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Introduction: Inflammation is related to insulin resistance in adults, especially on those individuals with high levels of body composition. 
Objectives: The aim of this study is to assess the relationship between a set of inflammatory biomarkers and insulin resistance by levels of body composition in a sample of European adolescents.
Material and methods: 962 adolescents (442 boys and 520 girls) from 9 European countries met the inclusion criteria of having measurements for the homeostasis model assessment (HOMA) and a set of inflammation-related biomarkers: C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), interleukin (IL-6), complement factors C3 and C4 and selected cell adhesion molecules. Body mass index (BMI), fat mass index (FMI) and waist circumference (WC) were categorized using tertiles. To assess the associations stratifying by body composition indexes, ANOVA and linear regression models were performed 
Results: Mean biomarkers’ concentrations differed across BMI, FMI and WC tertiles (p<0.05), by sex. In both sexes, insulin, HOMA, CRP, C3 and C4 were significantly different between categories (p<0.001), always showing the highest mean concentration in the upper category of BMI, FMI and WC. The most consistent finding was an association between insulin resistance and C3 concentrations (p<0.05), in the adolescents in the highest tertile of BMI, FMI and WC, except in the case of FMI in girls. 
Conclusion: Inflammatory and glucose metabolism markers differed by tertiles of body composition, being usually higher in the highest tertile. C3 complement factor was associated with insulin resistance in adolescents, especially those with high total and abdominal adiposity. 









Obesity is a condition in which the adipose tissue mass is increased due to a high adipocytes number and size (). In obese individuals, the endocrine function of the adipose tissue is impaired and the adipocytes, as well as the pre-adipocytes, macrophages, and adipose stem cells, contribute to the production of pro-inflammatory cytokines (). Both the hypertrophied adipocytes and other adipose tissue immune cells could lead to chronic inflammation through innate and adaptive immune responses  ADDIN EN.CITE (). Additionally, the adipose tissue dysfunction is related with the development of co-morbidities such as insulin resistance, type 2 diabetes and cardiovascular diseases (). The inflammatory state triggered by the impaired function of the adipose tissue, seems also to be related with these comorbidities  ADDIN EN.CITE (, ).
Among a large number of inflammatory-related biomarkers, C-reactive protein (CRP) has been the one most widely used. Hepatic synthesis of CRP, complement factors C3 and C4, depends on pro-inflammatory cytokines released by the adipose tissue such as tumor necrosis factor alpha (TNF-α) or interleukin 6 (IL-6) (). Moreover, cell adhesion molecules are elevated during inflammatory conditions and have been suggested as markers for atherosclerosis  ADDIN EN.CITE (). 









The HELENA study is a cross-sectional multi-center study (n=3528) conducted between 2006 and 2007 in 10 European cities: Athens and Heraklion in Greece, Dortmund in Germany, Ghent in Belgium, Lille in France, Pecs in Hungary, Rome in Italy, Stockholm in Sweden, Vienna in Austria and Zaragoza in Spain. General procedures and methodology of the HELENA study have been previously described  ADDIN EN.CITE (). 
The study was performed according to the ethical guidelines of the Edinburgh revision of the 1964 Declaration of Helsinki (2000), the International Conferences on Harmonization for Good Clinical Practice and the legislation on clinical research from each of the participating countries. The local Ethics Committees of each center approved the protocol. Written informed consent was obtained from the adolescents and their parents.  

2.2 Study sample
Blood collection was randomly performed in approximately a third of the total sample (n=1089, 31%). 962 participants (442 boys and 520 girls) met the inclusion criteria of having measured the homeostasis model assessment (HOMA) and the set of biomarkers related with inflammation: TNF-α, IL-6, CRP, complement factors C3 and C4 and cell adhesion molecules: vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), sE-selectin and L-selectin.

2.3 Physical measurements
Weight and height were measured in underwear and barefoot with an electronic scale (SECA 861, Seca Ltd, Birmingham, UK) and a stadiometer (SECA 225, Seca Ltd). In addition, body mass index (BMI) was calculated as body weight in kilograms divided by the square of height in meters. From Skinfolds, percentage of fat was calculated using the Slaughter formula and then the fat mass index was also calculated (kg/m2) (). Waist circumference was measured with an un-elastic tape. All anthropometric measures were taken following a standardized protocol. Inter-observer reliability for skinfold thicknesses and circumferences measurements was always greater than 90%  ADDIN EN.CITE ().

2.4 Blood analysis
Blood withdrawal was performed after 12 hours overnight fast. C-reactive protein (CRP) levels were quantified by immunoturbidimetry (AU 2700, Olimpus, Rungis, France). Adolescents with higher CRP concentrations than 10 mg/dL were excluded. Serum C3 and C4 complement factors were analyzed by nephelometry (Behring Diagnostics, CA, USA). The coefficient of variation (inter-assay precision) was 1.9% for CRP, 1.4% for C3, and 1.2% for C4. Serum cytokines IL-6 and TNF-α were determined using the High Sensitivity Human Cytokine MILLIPLEX™ MAP kit (Millipore Corp., Billerica, MA, USA) and collected by flow cytometry (Luminex-100 v.2.3, Luminex Corporation, Austin, TX, USA). The intra- and inter-assay precision CVs were: 3.5% and 4.5%, respectively, for IL-6; and 3.5% and 3.8%, respectively, for TNF-α. Detection limits (sensitivity) for all the analyses were 0.007 mg/l for CRP, 0.01 g/l for C3, 0.002 g/l for C4, 0.1 pg/ml for IL-6, and 0.05 pg/ml for TNF-α. Undetectable values were recorded as the specific detection limit. Children with values of 0.12 pg/mL for TNF-α and IL-6 were excluded as it was an assigned value for children with concentration values under the detection curve. The serum adhesion molecule sL-selectin was analysed through commercial ELISA kits (Diaclone, France), the sensitivities of this kit was less than 1 ng/mL for L-selectin. The analysed by Universal Microplate Spectophotometer (Power WaveTM XS, Biotek® Instruments, INC USA).
The multiplex assay kit, were used to detect for the simultaneous quantification of the following molecules sE-Selectin, sVCAM-1, sICAM-1, in serum. The samples were analysed by citometry (Luminex ®100). The sensitivities of these assay were: Min DC 0.079 ng/mL for  sE-Selectin, 0.016 ng/mL for sVCAM-1 and 0.009 ng/mL for sICAM-1. The intra-assay CV were 11.2% for sE-Selectin, 4.5% for sVCAM-1 and 7.9% for sICAM-1.

2.5 Statistical analysis
Analyses were performed separately for boys and girls. Normality of distributions was assessed with the Kolmogorov–Smirnov test. Glucose, Insulin, HOMA, CRP, IL6, TNF-α, L-selectin, sE-selectin and sICAM were normalized by natural logarithm transformation. T tests were used for comparisons of continuous variables by sex.
For BMI, FMI and WC, the standardized regression residuals by age were calculated and then categorized in tertiles.
Analysis of variance (ANOVA) with Bonferroni post-hoc correction was applied to compare mean differences of each biomarker between the categories of each indicator of body composition.
Finally, multiple linear regressions were performed to assess the association between HOMA-IR (dependent) and each marker of inflammation (independent) adjusted by center within body composition tertiles (BMI, FMI or WC). The effect of the city of residence was controlled in all regressions by using dummy variables. The dependent variable, HOMA-IR, was log-transformed. For markers of inflammation that were also log-transformed, results were expressed as percentage of change of the geometrical mean of the HOMA-IR for 10% increases of the corresponding biomarker. If the independent variable was normally distributed results were expressed as percentage of change of the geometrical mean of HOMA per unit increase of the corresponding biomarker. 








Descriptive characteristics are presented in Table 1. Boys were significantly taller and heavier than girls and had significantly higher values of waist circumference whereas girls had higher levels of FMI. Regarding the biomarkers measured, boys had significantly higher concentrations of glucose, HOMA, IL-6, TNF-α, L-selectin, sE-selectin, sVCAM-1 and sICAM-1 than girls while girls had significantly higher levels of insulin and C3 than boys. 

Results for the ANOVA are presented in Table 2, 3 and 4. Significant differences were found in mean values of the measured biomarkers across categories of each marker of body composition, by sex. When BMI increased, the mean concentrations of insulin and HOMA in boys, CRP in girls and C3 and C4, in both sexes, significantly increased (p<0.001). Also, CRP and sE-selectin in boys, and insulin, HOMA and sVCAM-1 in girls presented also significantly different mean values across categories. Also, when FMI increased, the mean levels of glucose in boys, CRP in girls and insulin, HOMA, C3 and C4, in both sexes, significantly increased (p<0.001). Additionally, CRP in boys and sVCAM-1 presented also significant differences (p<0.001) across categories. Finally, when WC increased, the mean level of insulin in boys and CRP in girls increased (p0.001); HOMA, CRP, C3 and C4 significantly increased (p<0.001), in both sexes. Mean values of sVCAM-1 presented also significant differences (p=0.024) between waist circumference categories but only in girls. 

Tables 5, 6 and 7 show results of the linear regression between HOMA-IR and the markers of inflammation for each body composition index. Table 5 show the results of the linear regression by tertiles of BMI. In the lowest tertile, in girls, HOMA-IR increased in a 31.1% and 22.7% per each additional g/L of C3 and C4, respectively, and in 2.0% and in 2.4% when TNF-alpha and IL-6 increases by 10%, respectively. Also, in the second tertile of BMI, we expect about 23.7% increase in HOMA-IR per each additional g/L of C3 and about 14.8% decrease in HOMA-IR per each additional ng/ml of sICAM-1. Moreover, in the highest tertile of BMI, in girls, HOMA-IR increased by 22.3% and 17.7% per each additional ng/ml of sICAM-1 and 1.5% when sE-selectin increases by 10%. Significant associations between HOMA-IR and C3 in the highest tertile of BMI in both sexes were found: HOMA-IR increased in a 17.7% per each additional g/L of C3 in girls and 27.7% per each additional g/L of C3 in boys.
Table 6 present the results of the linear regression between HOMA-IR and the markers of inflammation by tertiles of FMI. In the lowest tertile, HOMA-IR increased in a 1.8% when IL-6 increased 10% and in a 31.5% per each additional g/L of C3, in girls. Furthermore, in the second tertile of FMI, we expect about 1.9% increase in HOMA-IR when TNF-α increases by 10%, in girls. Moreover, in the highest tertile of BMI, HOMA-IR increased by 20.5% per each additional g/L of C3, in boys.







The main finding of this study is the consistent significant association between C3 complement factor and insulin resistance, irrespective of total and abdominal fat deposition. To our knowledge, this is the first study assessing the relationship between different inflammatory markers and insulin resistance in a relatively large sample of European adolescents, from different cities. 
In our sample, mean concentrations of glucose, insulin, HOMA and some inflammatory markers such as CRP or C3 and C4 were significantly higher in the highest tertile of each marker of body composition. Even in children, obesity has been related with low-grade inflammation (). Adipocyte hypertrophy has been associated with HOMA- insulin resistance and inflammation in obese children  ADDIN EN.CITE (). Results from our study also support the hypothesis that, even in adolescence, there is a link between adiposity, glucose metabolism and inflammation as some of these biomarkers were increased in the highest levels of total and abdominal adiposity.
Furthermore, in the present study there were linear associations between some inflammatory markers and HOMA as dependent variable, by categories of body composition indices. Previous studies suggest that inflammatory markers can interfere with insulin action by directly inhibiting insulin receptors (). However, there are some discrepancies between studies regarding the relationship between inflammation and insulin resistance in adolescents  ADDIN EN.CITE (, ). A recent study in obese adolescents failed to show a significant relation between obesity and IR mediated by low-grade inflammation using traditional inflammatory markers ().  
Although previous studies have associated some traditional inflammatory biomarkers with the development of diabetes or insulin resistance  ADDIN EN.CITE (), we did not find any relationship between the traditional inflammatory markers and the HOMA for adolescents with the highest levels of BMI, FMI and WC. Out of all the inflammatory markers measured in the present study, only C3 was consistently related with insulin resistance, measured by HOMA, especially in the highest tertiles of total and abdominal adiposity, except FMI in girls. Our results are in line with some previous studies. Serum C3 was the strongest inflammatory marker related with insulin resistance in a study in an elderly population  ADDIN EN.CITE (). This complement factor is an emerging cardio metabolic risk factor related with some comorbities such as type 2 diabetes (). In a sample of Spanish adolescents serum C3 levels were related with body fat, especially with abdominal obesity  ADDIN EN.CITE () and were higher in adult subjects with insulin resistance  ADDIN EN.CITE (). A previous study performed in adults showed that low-grade inflammation and insulin resistance might represent two independent pathways by which body fat leads to elevated C3  ADDIN EN.CITE (). However, it seems that changes in C3 levels over a 7-year follow-up period were associated with changes in several measures of insulin resistance and that baseline C3 was associated with the 7-year incidence of type 2 diabetes  ADDIN EN.CITE (). Although main production of the C3 is in the liver, C3 is also synthesized by activated macrophages () and adipocytes () as an inflammatory cytokine or an adipokine. Its hepatic production is induced by cytokines, such as interleukin-6 and TNF-α () which may interfere with insulin receptor functioning and cause insulin resistance (). In addition, the complement system is a regulator of both the innate and adaptive system and, as a part of the inflammatory response, could also contribute to insulin resistance. We also found associations between insulin resistance and C4 complement factor in girls. Production of C4 depends, as production of C3, on proinflammatory cytokines released by the adipose tissue such as tumor necrosis factor alpha (TNF-α) or interleukin 6 (IL-6) (). However, literature on the relationship between C4 and insulin resistance is scarce.
In our study, associations between TNF-α and insulin resistance were found in girls, in the lowest tertiles of body fat composition but not in the highest tertiles. TNF-α  interferes negatively with the insulin signaling pathway, but also induces insulin resistance indirectly by altering adipocyte differentiation and adipocyte lipid metabolism ().
This study has strengths as well as some limitations. First, the cross-sectional design which does not allow drawing conclusions on causality; however, in adults it was observed that C3 was associated with the development of insulin resistance in a longitudinal study  ADDIN EN.CITE (). Furthermore, the study is limited by the fact that blood samples only reflect inflammation, glucose and insulin concentrations at a given specific time point. On the other hand, the strengths of the study are: the use of traditional and non-traditional inflammatory markers that could be also involved in the pathogenesis of insulin resistance, the use of standardized and harmonized information on body composition of adolescents from 9 European countries. 

4.1 Conclusions
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Table II. Mean differences and standard deviations of biomarkers in boys and girls by body mass index categories.




































Table III. Mean differences and standard deviations of biomarkers in boys and girls by fat mass index categories.




































Table IV. Mean differences and standard deviations of biomarkers in boys and girls by waist circumference categories.




































Table V. Linear regression with HOMA-IR as dependent variable and the markers of inflammation as independent variables for each category of body mass index (adjust: center).






























Table VI. Linear regression with HOMA-IR as dependent variable and the markers of inflammation as independent variables for each category of fat mass index (adjust: center).






























Table VII. Linear regression with HOMA-IR as dependent variable and the markers of inflammation as independent variables for each category of waist circumference (adjust: country).

























WC: waist circumference; HOMA: Homeostasis model assessment; CRP: C-reactive protein; IL-6: interleukin 6; TNF-α: tumor necrosis factor alpha; C3 and C4: complement factors; sVCAM-1: soluble vascular cell adhesion protein 1; sICAM1: soluble Intercellular Adhesion Molecule 1. †Biomarkers log-transformed.
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